ADPT News and Press, Adaptive Biotechnologies Corporation From 01/12/26

SEATTLE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced preliminary, unaudited r...

SEATTLE, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating...

2025-12-26 09:22:10 ET Introduction Adaptive Biotechnologies Corporation's ( ADPT ) stock has advanced another 15% since my rating upgrade to Hold in October. In fact, Seeking Alpha noted that Adaptive was the top-performing life sciences tools and services stock in 2025...

2025-12-23 00:06:46 ET More on Adaptive Biotechnologies, The Health Care Select Sector SPDR® Fund ETF, etc. Read the full article on Seeking Alpha For further details see: Adaptive Biotechnologies is the top performing life sciences tools and services stock YTD

A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis A data licensing agreement to access Adaptive’s proprietary TCR-antigen datasets for research and development in multiple immunology applications SEATTLE, Dec. 15, 2025 (...

SEATTLE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced Dr. Harlan Robins, Chief...

2025-12-09 04:20:00 ET The vast majority of asset management companies today use model portfolios. Model portfolios, which surged to a record $7.7 trillion in assets in early 2025, offer a way for advisors to outsource portfolio construction and rebalancing. The proliferation of model p...

2025-12-08 05:22:02 ET Read the full article on Seeking Alpha For further details see: Cathie Wood's weekly recap: heads turn to AI, biotech; sells communication names

SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced growing interventional use of ...

SEATTLE, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced that its next-generation seque...